Muhammad Nadeem Abbas

Dr. Muhammad Nadeem Abbas


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2019 in Cancers
Verified
Journal Article
Open access
PDF file
EZErhu Zhao
Erhu Zhao
JHJianbing Hou
Jianbing Hou
XKXiaoxue Ke
Xiaoxue Ke
MAMuhammad Nadeem Abbas
Muhammad Nadeem Abbas
SKSaima Kausar
Saima Kausar
HCHongjuan Cui
Hongjuan Cui
Sirtuin family members are characterized by either mono-ADP-ribosyltransferase or deacylase activity and are linked to various cancer-related biological pathways as regulators of transcriptional progression. Sirtuins play fundamental roles in carcinogenesis and maintenance of the malignant phenotype, mainly participating in cancer cell viability, apoptosis, metastasis, and tumorigenesis. Although sirtuin family members have a high degree of homology, they may play different roles in various kinds of cancer. This review highlights their fundamental roles in tumorigenesis and cancer development and provides a critical discussion of their dual roles in cancer, namely, as tumor promoters or tumor suppressors.

19 May 2023 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
SWSicheng Wan
Sicheng Wan
GZGuanghui Zhang
Guanghui Zhang
RLRuochen Liu
Ruochen Liu
MAMuhammad Nadeem Abbas
Muhammad Nadeem Abbas
HCHongjuan Cui
Hongjuan Cui
Glioma is a common primary tumor of the central nervous system (CNS), with glioblastoma multiforme (GBM) being the most malignant, aggressive, and drug resistant. Most drugs are designed to induce cancer cell death, either directly or indirectly, but malignant tumor cells can always evade death and continue to proliferate, resulting in a poor prognosis for patients. This reflects our limited understanding of the complex regulatory network that cancer cells utilize to avoid death. In addition to classical apoptosis, pyroptosis, ferroptosis, and autophagy are recognized as key cell death modalities that play significant roles in tumor progression. Various inducers or inhibitors have been discovered to target the related molecules in these pathways, and some of them have already been translated into clinical treatment. In this review, we summarized recent advances in the molecular mechanisms of inducing or inhibiting pyroptosis, ferroptosis, or autophagy in GBM, which are important for treatment or drug tolerance. We also discussed their links with apoptosis to better understand the mutual regulatory network among different cell death processes.

Verified
Journal Article
Open access
PDF file
ZDZhen Dong
Zhen Dong
MAMuhammad Nadeem Abbas
Muhammad Nadeem Abbas
SKSaima Kausar
Saima Kausar
JYJie Yang
Jie Yang
LLLin Li
Lin Li
HCHongjuan Cui
Hongjuan Cui
As an FDA-approved drug, glycylcycline tigecycline has been used to treat complicated microbial infections. However, recent studies in multiple hematologic and malignant solid tumors reveal that tigecycline treatment induces cell cycle arrest, apoptosis, autophagy and oxidative stress. In addition, tigecycline also inhibits mitochondrial oxidative phosphorylation, cell proliferation, migration, invasion and angiogenesis. Importantly, combinations of tigecycline with chemotherapeutic or targeted drugs such as venetoclax, doxorubicin, vincristine, paclitaxel, cisplatin, and imatinib, have shown to be promising strategies for cancer treatment. Mechanism of action studies reveal that tigecycline leads to the inhibition of mitochondrial translation possibly through interacting with mitochondrial ribosome. Meanwhile, this drug also interferes with several other cell pathways/targets including MYC, HIFs, PI3K/AKT or AMPK-mediated mTOR, cytoplasmic p21 CIP1/Waf1, and Wnt/β-catenin signaling. These evidences indicate that antibiotic tigecycline is a promising drug for cancer treatment alone or in combination with other anticancer drugs. This review summarizes the biological function of tigecycline in the treatment of tumors and comprehensively discusses its mode of action.


1 March 2020 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
MAMuhammad Nadeem Abbas
Muhammad Nadeem Abbas
SKSaima Kausar
Saima Kausar
EZErhu Zhao
Erhu Zhao
HCHongjuan Cui
Hongjuan Cui

1 November 2017 in Journal of Insect Physiology
Verified
Journal Article
Closed access
MAMuhammad Nadeem Abbas
Muhammad Nadeem Abbas
BZBaojian Zhu
Baojian Zhu
SKSaima Kausar
Saima Kausar
LDLi-Shang Dai
Li-Shang Dai
YSYu-Xuan Sun
Yu-Xuan Sun
CLChaoliang Liu
Chaoliang Liu